We are live on
!
Find out more
BMA
Brooks Moore & Associates Portfolio holdings
AUM
$199M
1-Year Est. Return
21.09%
This Fund
S&P 500
This Quarter
Est. Return
+11.02%
1 Year Est. Return
+21.09%
3 Year Est. Return
+57.25%
5 Year Est. Return
+77.34%
10 Year Est. Return
–
AUM
$170M
AUM Growth
+$17.7M
(+12%)
Cap. Flow
+$2.44M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
31.73%
Holding
100
New
4
Increased
23
Reduced
45
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.18M |
| 2 |
PARAA
Paramount Global Class A
PARAA
|
+$1.06M |
| 3 |
Webster Financial
WBS
|
+$880K |
| 4 |
Encompass Health
EHC
|
+$724K |
| 5 |
Cisco
CSCO
|
+$613K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$982K |
| 2 |
Bristol-Myers Squibb
BMY
|
+$879K |
| 3 |
Organon & Co
OGN
|
+$715K |
| 4 |
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
|
+$398K |
| 5 |
Lockheed Martin
LMT
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.23% |
| 2 | Healthcare | 15.27% |
| 3 | Consumer Staples | 12.01% |
| 4 | Financials | 10.96% |
| 5 | Industrials | 9.41% |
Similar funds
FWM
SWMP
SCM
LCM
SPI
FU
FA
BHA
Brooks Moore & Associates's Q4 2021 Portfolio in Review
As of Q4 2021, Brooks Moore & Associates held 100 positions worth $170M, up 12% from $153M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Brooks Moore & Associates's Q4 2021 filing shows 4 new, 23 increased, 45 reduced and 3 closed positions. Its largest new stake was Paramount Global Class A: 28,225 shares worth $852K. The largest sale was Fiserv Inc, an estimated $982K.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.
- Brooks Moore & Associates's largest Q4 2021 buy was Paramount Global Class A: 28,225 shares worth $852K.
- Brooks Moore & Associates added most to JPMorgan Ultra-Short Income ETF in Q4 2021, an estimated $1.18M increase.
- Brooks Moore & Associates's biggest Q4 2021 reduction was Bristol-Myers Squibb, cutting an estimated $879K.
- Brooks Moore & Associates fully exited Fiserv Inc in Q4 2021, selling an estimated $982K.
- Brooks Moore & Associates's ten largest holdings make up 32% of its $170M portfolio in Q4 2021.
- Brooks Moore & Associates opened 4 new positions and closed 3 in Q4 2021.
- Brooks Moore & Associates's portfolio value rose 12% quarter-over-quarter to $170M.
Based on Brooks Moore & Associates's 13F filing for Q4 2021, filed 4 Feb 2022.